SOW
NRIX icon

State of Wyoming’s Nurix Therapeutics NRIX Stock Holding History

State of Wyoming’s Portfolio NRIX Stock Details NRIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$112K Buy
+4,605
New +$78.4K 0.01% 1349
2022
Q3 		– Sell
-209
Closed -$3K – 1798
2022
Q2 		$3K Sell
209
-1,094
-84% -$12.4K ﹤0.01% 1760
2022
Q1 		$18K Buy
1,303
+422
+48% +$7.49K 0.01% 1467
2021
Q4 		$26K Buy
881
+119
+16% +$3.61K 0.01% 1408
2021
Q3 		$23K Sell
762
-459
-38% -$14.2K 0.01% 917
2021
Q2 		$32K Buy
1,221
+806
+194% +$23.7K 0.02% 848
2021
Q1 		$13K Buy
+415
New +$15.7K 0.02% 363

Other funds holding NRIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State of Wyoming's NRIX Position: Q2 2026 in Review

State of Wyoming opened a new position in Nurix Therapeutics (NRIX) in Q2 2026: 4,605 shares worth $112K. The stake represents 0.01% of the portfolio and ranks #1349 among its holdings. This is a return to the name: State of Wyoming previously reported a position in NRIX as recently as Q2 2022.

State of Wyoming first reported a position in NRIX in Q1 2021 and has held it in 7 quarters since. 211 funds tracked by Wall St. Rank hold NRIX as of Q2 2026.

  • State of Wyoming held 4,605 shares of Nurix Therapeutics worth $112K as of Q2 2026.
  • Nurix Therapeutics was a new State of Wyoming position in Q2 2026.
  • Nurix Therapeutics made up 0.01% of State of Wyoming's portfolio in Q2 2026, its #1349 holding.
  • State of Wyoming first reported a position in Nurix Therapeutics in Q1 2021 and has held it in 7 quarters since.
  • 211 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.